nodes	percent_of_prediction	percent_of_DWPC	metapath
Naloxone—CYP2C8—Ifosfamide—germ cell cancer	0.112	0.189	CbGbCtD
Naloxone—SLCO1A2—Methotrexate—germ cell cancer	0.0886	0.149	CbGbCtD
Naloxone—ABCB1—Dactinomycin—germ cell cancer	0.0643	0.108	CbGbCtD
Naloxone—CYP2C8—Etoposide—germ cell cancer	0.0536	0.0903	CbGbCtD
Naloxone—ALB—Methotrexate—germ cell cancer	0.0458	0.0772	CbGbCtD
Naloxone—CYP3A4—Ifosfamide—germ cell cancer	0.0455	0.0767	CbGbCtD
Naloxone—ABCB1—Vinblastine—germ cell cancer	0.0402	0.0679	CbGbCtD
Naloxone—ABCB1—Cisplatin—germ cell cancer	0.0369	0.0622	CbGbCtD
Naloxone—ABCB1—Etoposide—germ cell cancer	0.0363	0.0611	CbGbCtD
Naloxone—CREB1—adrenal medulla—germ cell cancer	0.0288	0.135	CbGeAlD
Naloxone—CYP3A4—Vinblastine—germ cell cancer	0.0241	0.0407	CbGbCtD
Naloxone—ABCB1—Methotrexate—germ cell cancer	0.024	0.0404	CbGbCtD
Naloxone—CYP3A4—Etoposide—germ cell cancer	0.0217	0.0366	CbGbCtD
Naloxone—CREB1—telencephalic ventricle—germ cell cancer	0.0115	0.0537	CbGeAlD
Naloxone—CREB1—ganglion—germ cell cancer	0.00716	0.0334	CbGeAlD
Naloxone—TLR4—eye—germ cell cancer	0.00688	0.0321	CbGeAlD
Naloxone—OPRM1—telencephalic ventricle—germ cell cancer	0.0062	0.0289	CbGeAlD
Naloxone—TLR4—decidua—germ cell cancer	0.00595	0.0278	CbGeAlD
Naloxone—OPRD1—ganglion—germ cell cancer	0.00566	0.0264	CbGeAlD
Naloxone—TLR4—adrenal gland—germ cell cancer	0.00457	0.0213	CbGeAlD
Naloxone—TLR4—bone marrow—germ cell cancer	0.00442	0.0206	CbGeAlD
Naloxone—TLR4—female gonad—germ cell cancer	0.00426	0.0199	CbGeAlD
Naloxone—CREB1—neck—germ cell cancer	0.00407	0.019	CbGeAlD
Naloxone—OPRM1—ganglion—germ cell cancer	0.00386	0.018	CbGeAlD
Naloxone—TLR4—testis—germ cell cancer	0.00378	0.0176	CbGeAlD
Naloxone—CREB1—trigeminal ganglion—germ cell cancer	0.00352	0.0164	CbGeAlD
Naloxone—TLR4—cerebellum—germ cell cancer	0.00349	0.0163	CbGeAlD
Naloxone—CREB1—embryo—germ cell cancer	0.0034	0.0159	CbGeAlD
Naloxone—CREB1—brainstem—germ cell cancer	0.00311	0.0145	CbGeAlD
Naloxone—CREB1—eye—germ cell cancer	0.00303	0.0141	CbGeAlD
Naloxone—CREB1—retina—germ cell cancer	0.003	0.014	CbGeAlD
Naloxone—TLR4—brain—germ cell cancer	0.00283	0.0132	CbGeAlD
Naloxone—CREB1—telencephalon—germ cell cancer	0.00276	0.0129	CbGeAlD
Naloxone—TLR4—lymph node—germ cell cancer	0.00274	0.0128	CbGeAlD
Naloxone—CREB1—skin of body—germ cell cancer	0.00264	0.0123	CbGeAlD
Naloxone—CREB1—decidua—germ cell cancer	0.00262	0.0122	CbGeAlD
Naloxone—CYP3A4—urine—germ cell cancer	0.00231	0.0108	CbGeAlD
Naloxone—CREB1—gonad—germ cell cancer	0.00231	0.0108	CbGeAlD
Naloxone—CREB1—uterus—germ cell cancer	0.00229	0.0107	CbGeAlD
Naloxone—CREB1—pituitary gland—germ cell cancer	0.00225	0.0105	CbGeAlD
Naloxone—ESR1—blood vessel—germ cell cancer	0.00224	0.0105	CbGeAlD
Naloxone—OPRD1—telencephalon—germ cell cancer	0.00218	0.0102	CbGeAlD
Naloxone—CREB1—medulla oblongata—germ cell cancer	0.00217	0.0101	CbGeAlD
Naloxone—CREB1—adrenal gland—germ cell cancer	0.00201	0.00938	CbGeAlD
Naloxone—CREB1—midbrain—germ cell cancer	0.00198	0.00926	CbGeAlD
Naloxone—CREB1—bone marrow—germ cell cancer	0.00194	0.00907	CbGeAlD
Naloxone—CREB1—spinal cord—germ cell cancer	0.00194	0.00903	CbGeAlD
Naloxone—CREB1—female gonad—germ cell cancer	0.00187	0.00874	CbGeAlD
Naloxone—Ventricular fibrillation—Ifosfamide—germ cell cancer	0.00181	0.0299	CcSEcCtD
Naloxone—CREB1—endocrine gland—germ cell cancer	0.00174	0.00813	CbGeAlD
Naloxone—CREB1—head—germ cell cancer	0.00172	0.00803	CbGeAlD
Naloxone—OPRM1—brainstem—germ cell cancer	0.00168	0.00783	CbGeAlD
Naloxone—CREB1—testis—germ cell cancer	0.00166	0.00776	CbGeAlD
Naloxone—ESR1—neck—germ cell cancer	0.0016	0.00748	CbGeAlD
Naloxone—CREB1—cerebellum—germ cell cancer	0.00153	0.00716	CbGeAlD
Naloxone—OPRM1—telencephalon—germ cell cancer	0.00149	0.00695	CbGeAlD
Naloxone—Rhinorrhoea—Cisplatin—germ cell cancer	0.00148	0.0244	CcSEcCtD
Naloxone—Ventricular tachycardia—Ifosfamide—germ cell cancer	0.00139	0.0229	CcSEcCtD
Naloxone—OPRD1—head—germ cell cancer	0.00136	0.00635	CbGeAlD
Naloxone—ESR1—embryo—germ cell cancer	0.00134	0.00624	CbGeAlD
Naloxone—OPRK1—head—germ cell cancer	0.0013	0.00608	CbGeAlD
Naloxone—SLCO1A2—telencephalon—germ cell cancer	0.00128	0.00598	CbGeAlD
Naloxone—Coma—Ifosfamide—germ cell cancer	0.00127	0.0209	CcSEcCtD
Naloxone—CREB1—brain—germ cell cancer	0.00125	0.00582	CbGeAlD
Naloxone—Pulmonary oedema—Ifosfamide—germ cell cancer	0.00124	0.0204	CcSEcCtD
Naloxone—ESR1—brainstem—germ cell cancer	0.00123	0.00572	CbGeAlD
Naloxone—CREB1—lymph node—germ cell cancer	0.0012	0.00562	CbGeAlD
Naloxone—OPRK1—cerebellum—germ cell cancer	0.00116	0.00543	CbGeAlD
Naloxone—ESR1—telencephalon—germ cell cancer	0.00109	0.00508	CbGeAlD
Naloxone—Depression—Vinblastine—germ cell cancer	0.00107	0.0177	CcSEcCtD
Naloxone—OPRM1—midbrain—germ cell cancer	0.00107	0.00499	CbGeAlD
Naloxone—OPRM1—spinal cord—germ cell cancer	0.00104	0.00487	CbGeAlD
Naloxone—ESR1—decidua—germ cell cancer	0.00103	0.00481	CbGeAlD
Naloxone—Encephalopathy—Methotrexate—germ cell cancer	0.00102	0.0169	CcSEcCtD
Naloxone—SLCO1A2—medulla oblongata—germ cell cancer	0.00101	0.0047	CbGeAlD
Naloxone—OPRD1—brain—germ cell cancer	0.000986	0.0046	CbGeAlD
Naloxone—Cardiac arrest—Ifosfamide—germ cell cancer	0.000958	0.0158	CcSEcCtD
Naloxone—OPRK1—brain—germ cell cancer	0.000945	0.00441	CbGeAlD
Naloxone—OPRM1—endocrine gland—germ cell cancer	0.00094	0.00438	CbGeAlD
Naloxone—OPRM1—head—germ cell cancer	0.000928	0.00433	CbGeAlD
Naloxone—ALB—adrenal gland—germ cell cancer	0.000927	0.00433	CbGeAlD
Naloxone—SLCO1A2—midbrain—germ cell cancer	0.000921	0.0043	CbGeAlD
Naloxone—ESR1—gonad—germ cell cancer	0.000908	0.00424	CbGeAlD
Naloxone—ESR1—uterus—germ cell cancer	0.000902	0.00421	CbGeAlD
Naloxone—SLCO1A2—spinal cord—germ cell cancer	0.000898	0.00419	CbGeAlD
Naloxone—OPRM1—testis—germ cell cancer	0.000896	0.00418	CbGeAlD
Naloxone—ESR1—pituitary gland—germ cell cancer	0.000886	0.00413	CbGeAlD
Naloxone—ABCB1—blood vessel—germ cell cancer	0.000885	0.00413	CbGeAlD
Naloxone—Irritability—Cisplatin—germ cell cancer	0.000829	0.0137	CcSEcCtD
Naloxone—SLCO1A2—endocrine gland—germ cell cancer	0.000809	0.00377	CbGeAlD
Naloxone—SLCO1A2—head—germ cell cancer	0.000798	0.00373	CbGeAlD
Naloxone—ESR1—adrenal gland—germ cell cancer	0.000791	0.00369	CbGeAlD
Naloxone—Nasopharyngitis—Cisplatin—germ cell cancer	0.000777	0.0128	CcSEcCtD
Naloxone—SLCO1A2—testis—germ cell cancer	0.000771	0.0036	CbGeAlD
Naloxone—ALB—testis—germ cell cancer	0.000767	0.00358	CbGeAlD
Naloxone—Flushing—Bleomycin—germ cell cancer	0.000757	0.0125	CcSEcCtD
Naloxone—Cardiac arrest—Etoposide—germ cell cancer	0.000757	0.0125	CcSEcCtD
Naloxone—ESR1—female gonad—germ cell cancer	0.000738	0.00344	CbGeAlD
Naloxone—Chills—Bleomycin—germ cell cancer	0.000732	0.0121	CcSEcCtD
Naloxone—CYP2C8—pituitary gland—germ cell cancer	0.000729	0.0034	CbGeAlD
Naloxone—Convulsion—Vinblastine—germ cell cancer	0.000729	0.012	CcSEcCtD
Naloxone—Hypertension—Vinblastine—germ cell cancer	0.000726	0.012	CcSEcCtD
Naloxone—SLCO1A2—cerebellum—germ cell cancer	0.000712	0.00332	CbGeAlD
Naloxone—Flushing—Dactinomycin—germ cell cancer	0.000706	0.0116	CcSEcCtD
Naloxone—Hallucination—Ifosfamide—germ cell cancer	0.000694	0.0114	CcSEcCtD
Naloxone—ESR1—endocrine gland—germ cell cancer	0.000686	0.0032	CbGeAlD
Naloxone—Chills—Dactinomycin—germ cell cancer	0.000683	0.0113	CcSEcCtD
Naloxone—ESR1—head—germ cell cancer	0.000677	0.00316	CbGeAlD
Naloxone—OPRM1—brain—germ cell cancer	0.000672	0.00314	CbGeAlD
Naloxone—ESR1—testis—germ cell cancer	0.000654	0.00305	CbGeAlD
Naloxone—Cardiac disorder—Ifosfamide—germ cell cancer	0.000647	0.0107	CcSEcCtD
Naloxone—Flushing—Ifosfamide—germ cell cancer	0.000647	0.0107	CcSEcCtD
Naloxone—Angiopathy—Ifosfamide—germ cell cancer	0.000633	0.0104	CcSEcCtD
Naloxone—Mediastinal disorder—Ifosfamide—germ cell cancer	0.000628	0.0104	CcSEcCtD
Naloxone—Chills—Ifosfamide—germ cell cancer	0.000626	0.0103	CcSEcCtD
Naloxone—Paraesthesia—Vinblastine—germ cell cancer	0.000616	0.0102	CcSEcCtD
Naloxone—Mental disorder—Ifosfamide—germ cell cancer	0.000611	0.0101	CcSEcCtD
Naloxone—ESR1—cerebellum—germ cell cancer	0.000604	0.00282	CbGeAlD
Naloxone—Coma—Methotrexate—germ cell cancer	0.0006	0.0099	CcSEcCtD
Naloxone—Pain—Vinblastine—germ cell cancer	0.000587	0.00968	CcSEcCtD
Naloxone—Pulmonary oedema—Methotrexate—germ cell cancer	0.000585	0.00964	CcSEcCtD
Naloxone—SLCO1A2—brain—germ cell cancer	0.000579	0.0027	CbGeAlD
Naloxone—ALB—brain—germ cell cancer	0.000575	0.00268	CbGeAlD
Naloxone—CYP2C8—endocrine gland—germ cell cancer	0.000565	0.00264	CbGeAlD
Naloxone—Flushing—Cisplatin—germ cell cancer	0.000558	0.0092	CcSEcCtD
Naloxone—Cardiac disorder—Cisplatin—germ cell cancer	0.000558	0.0092	CcSEcCtD
Naloxone—Agitation—Ifosfamide—germ cell cancer	0.000558	0.0092	CcSEcCtD
Naloxone—ALB—lymph node—germ cell cancer	0.000556	0.00259	CbGeAlD
Naloxone—ABCB1—trigeminal ganglion—germ cell cancer	0.000547	0.00255	CbGeAlD
Naloxone—Abdominal pain—Vinblastine—germ cell cancer	0.000542	0.00895	CcSEcCtD
Naloxone—Mediastinal disorder—Cisplatin—germ cell cancer	0.000542	0.00894	CcSEcCtD
Naloxone—CYP2C8—testis—germ cell cancer	0.000539	0.00252	CbGeAlD
Naloxone—ABCB1—embryo—germ cell cancer	0.000528	0.00246	CbGeAlD
Naloxone—Convulsion—Ifosfamide—germ cell cancer	0.000526	0.00867	CcSEcCtD
Naloxone—Hypertension—Ifosfamide—germ cell cancer	0.000524	0.00864	CcSEcCtD
Naloxone—Paraesthesia—Bleomycin—germ cell cancer	0.00052	0.00858	CcSEcCtD
Naloxone—Dyspnoea—Bleomycin—germ cell cancer	0.000517	0.00852	CcSEcCtD
Naloxone—Unspecified disorder of skin and subcutaneous tissue—Ifosfamide—germ cell cancer	0.000513	0.00846	CcSEcCtD
Naloxone—Flushing—Etoposide—germ cell cancer	0.000511	0.00843	CcSEcCtD
Naloxone—Cardiac disorder—Etoposide—germ cell cancer	0.000511	0.00843	CcSEcCtD
Naloxone—Angiopathy—Etoposide—germ cell cancer	0.0005	0.00824	CcSEcCtD
Naloxone—Mediastinal disorder—Etoposide—germ cell cancer	0.000496	0.00819	CcSEcCtD
Naloxone—Pain—Bleomycin—germ cell cancer	0.000496	0.00817	CcSEcCtD
Naloxone—Chills—Etoposide—germ cell cancer	0.000494	0.00815	CcSEcCtD
Naloxone—Asthenia—Vinblastine—germ cell cancer	0.000492	0.00812	CcSEcCtD
Naloxone—ESR1—brain—germ cell cancer	0.000491	0.00229	CbGeAlD
Naloxone—Tremor—Cisplatin—germ cell cancer	0.00049	0.00809	CcSEcCtD
Naloxone—Nervous system disorder—Ifosfamide—germ cell cancer	0.000486	0.00801	CcSEcCtD
Naloxone—Skin disorder—Ifosfamide—germ cell cancer	0.000481	0.00794	CcSEcCtD
Naloxone—Hyperhidrosis—Ifosfamide—germ cell cancer	0.000479	0.0079	CcSEcCtD
Naloxone—ESR1—lymph node—germ cell cancer	0.000474	0.00221	CbGeAlD
Naloxone—Diarrhoea—Vinblastine—germ cell cancer	0.00047	0.00774	CcSEcCtD
Naloxone—ABCB1—retina—germ cell cancer	0.000467	0.00218	CbGeAlD
Naloxone—Pain—Dactinomycin—germ cell cancer	0.000462	0.00762	CcSEcCtD
Naloxone—Body temperature increased—Bleomycin—germ cell cancer	0.000458	0.00756	CcSEcCtD
Naloxone—Irritability—Methotrexate—germ cell cancer	0.000455	0.00751	CcSEcCtD
Naloxone—Convulsion—Cisplatin—germ cell cancer	0.000453	0.00748	CcSEcCtD
Naloxone—Paraesthesia—Ifosfamide—germ cell cancer	0.000445	0.00734	CcSEcCtD
Naloxone—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—germ cell cancer	0.000442	0.0073	CcSEcCtD
Naloxone—Dyspnoea—Ifosfamide—germ cell cancer	0.000442	0.00728	CcSEcCtD
Naloxone—Vomiting—Vinblastine—germ cell cancer	0.000436	0.0072	CcSEcCtD
Naloxone—ABCB1—telencephalon—germ cell cancer	0.00043	0.002	CbGeAlD
Naloxone—Gastrointestinal disorder—Ifosfamide—germ cell cancer	0.000428	0.00705	CcSEcCtD
Naloxone—Abdominal pain—Dactinomycin—germ cell cancer	0.000427	0.00705	CcSEcCtD
Naloxone—Body temperature increased—Dactinomycin—germ cell cancer	0.000427	0.00705	CcSEcCtD
Naloxone—Pain—Ifosfamide—germ cell cancer	0.000424	0.00699	CcSEcCtD
Naloxone—Nervous system disorder—Cisplatin—germ cell cancer	0.000419	0.00691	CcSEcCtD
Naloxone—Tachycardia—Cisplatin—germ cell cancer	0.000417	0.00687	CcSEcCtD
Naloxone—Asthenia—Bleomycin—germ cell cancer	0.000416	0.00686	CcSEcCtD
Naloxone—Convulsion—Etoposide—germ cell cancer	0.000415	0.00685	CcSEcCtD
Naloxone—Skin disorder—Cisplatin—germ cell cancer	0.000415	0.00684	CcSEcCtD
Naloxone—Hypertension—Etoposide—germ cell cancer	0.000414	0.00683	CcSEcCtD
Naloxone—Hyperhidrosis—Cisplatin—germ cell cancer	0.000413	0.00681	CcSEcCtD
Naloxone—Nausea—Vinblastine—germ cell cancer	0.000408	0.00672	CcSEcCtD
Naloxone—ABCB1—decidua—germ cell cancer	0.000407	0.0019	CbGeAlD
Naloxone—Unspecified disorder of skin and subcutaneous tissue—Etoposide—germ cell cancer	0.000405	0.00668	CcSEcCtD
Naloxone—CYP2C8—brain—germ cell cancer	0.000404	0.00189	CbGeAlD
Naloxone—Abdominal pain—Ifosfamide—germ cell cancer	0.000392	0.00646	CcSEcCtD
Naloxone—Body temperature increased—Ifosfamide—germ cell cancer	0.000392	0.00646	CcSEcCtD
Naloxone—Asthenia—Dactinomycin—germ cell cancer	0.000388	0.0064	CcSEcCtD
Naloxone—Paraesthesia—Cisplatin—germ cell cancer	0.000383	0.00632	CcSEcCtD
Naloxone—CYP3A4—endocrine gland—germ cell cancer	0.000383	0.00179	CbGeAlD
Naloxone—Tachycardia—Etoposide—germ cell cancer	0.000382	0.0063	CcSEcCtD
Naloxone—Dyspnoea—Cisplatin—germ cell cancer	0.000381	0.00628	CcSEcCtD
Naloxone—Skin disorder—Etoposide—germ cell cancer	0.00038	0.00627	CcSEcCtD
Naloxone—Hyperhidrosis—Etoposide—germ cell cancer	0.000378	0.00624	CcSEcCtD
Naloxone—Diarrhoea—Dactinomycin—germ cell cancer	0.00037	0.0061	CcSEcCtD
Naloxone—Gastrointestinal disorder—Cisplatin—germ cell cancer	0.000369	0.00608	CcSEcCtD
Naloxone—Vomiting—Bleomycin—germ cell cancer	0.000369	0.00608	CcSEcCtD
Naloxone—Depression—Methotrexate—germ cell cancer	0.000366	0.00604	CcSEcCtD
Naloxone—Pain—Cisplatin—germ cell cancer	0.000365	0.00602	CcSEcCtD
Naloxone—ABCB1—gonad—germ cell cancer	0.000358	0.00167	CbGeAlD
Naloxone—ABCB1—uterus—germ cell cancer	0.000356	0.00166	CbGeAlD
Naloxone—Asthenia—Ifosfamide—germ cell cancer	0.000355	0.00586	CcSEcCtD
Naloxone—Sweating—Methotrexate—germ cell cancer	0.000352	0.00581	CcSEcCtD
Naloxone—Paraesthesia—Etoposide—germ cell cancer	0.000351	0.00579	CcSEcCtD
Naloxone—ABCB1—pituitary gland—germ cell cancer	0.00035	0.00163	CbGeAlD
Naloxone—Dyspnoea—Etoposide—germ cell cancer	0.000349	0.00575	CcSEcCtD
Naloxone—Nausea—Bleomycin—germ cell cancer	0.000344	0.00568	CcSEcCtD
Naloxone—Vomiting—Dactinomycin—germ cell cancer	0.000344	0.00567	CcSEcCtD
Naloxone—Diarrhoea—Ifosfamide—germ cell cancer	0.000339	0.00559	CcSEcCtD
Naloxone—Gastrointestinal disorder—Etoposide—germ cell cancer	0.000338	0.00557	CcSEcCtD
Naloxone—Body temperature increased—Cisplatin—germ cell cancer	0.000338	0.00557	CcSEcCtD
Naloxone—ABCB1—medulla oblongata—germ cell cancer	0.000338	0.00158	CbGeAlD
Naloxone—Pain—Etoposide—germ cell cancer	0.000335	0.00552	CcSEcCtD
Naloxone—Nausea—Dactinomycin—germ cell cancer	0.000321	0.0053	CcSEcCtD
Naloxone—TLR4—Innate Immune System—KIT—germ cell cancer	0.000318	0.0024	CbGpPWpGaD
Naloxone—Vomiting—Ifosfamide—germ cell cancer	0.000315	0.00519	CcSEcCtD
Naloxone—ABCB1—adrenal gland—germ cell cancer	0.000312	0.00146	CbGeAlD
Naloxone—CREB1—DAP12 interactions—FGFR3—germ cell cancer	0.000311	0.00235	CbGpPWpGaD
Naloxone—CREB1—Fc epsilon receptor (FCERI) signaling—FGFR3—germ cell cancer	0.000311	0.00235	CbGpPWpGaD
Naloxone—CREB1—Signaling by FGFR in disease—FGFR3—germ cell cancer	0.000311	0.00235	CbGpPWpGaD
Naloxone—ESR1—Signaling by ERBB4—KITLG—germ cell cancer	0.000309	0.00234	CbGpPWpGaD
Naloxone—Body temperature increased—Etoposide—germ cell cancer	0.000309	0.0051	CcSEcCtD
Naloxone—Abdominal pain—Etoposide—germ cell cancer	0.000309	0.0051	CcSEcCtD
Naloxone—ESR1—Signaling mediated by p38-alpha and p38-beta—TP53—germ cell cancer	0.000309	0.00234	CbGpPWpGaD
Naloxone—ABCB1—midbrain—germ cell cancer	0.000308	0.00144	CbGeAlD
Naloxone—CREB1—Signaling by EGFR—FGFR3—germ cell cancer	0.000308	0.00233	CbGpPWpGaD
Naloxone—CREB1—Downstream signal transduction—KIT—germ cell cancer	0.000308	0.00233	CbGpPWpGaD
Naloxone—Asthenia—Cisplatin—germ cell cancer	0.000306	0.00505	CcSEcCtD
Naloxone—CREB1—Signaling by FGFR—KIT—germ cell cancer	0.000306	0.00232	CbGpPWpGaD
Naloxone—Cardiac disorder—Methotrexate—germ cell cancer	0.000306	0.00505	CcSEcCtD
Naloxone—CREB1—Signaling by EGFR in Cancer—FGFR3—germ cell cancer	0.000305	0.00231	CbGpPWpGaD
Naloxone—CREB1—Developmental Biology—SOX2—germ cell cancer	0.000305	0.00231	CbGpPWpGaD
Naloxone—CREB1—Signaling by ERBB2—KIT—germ cell cancer	0.000305	0.00231	CbGpPWpGaD
Naloxone—CREB1—Signaling by PDGF—FGFR3—germ cell cancer	0.000304	0.0023	CbGpPWpGaD
Naloxone—CREB1—DAP12 signaling—KIT—germ cell cancer	0.000303	0.0023	CbGpPWpGaD
Naloxone—ESR1—Aryl Hydrocarbon Receptor—MYC—germ cell cancer	0.000302	0.00229	CbGpPWpGaD
Naloxone—ABCB1—bone marrow—germ cell cancer	0.000302	0.00141	CbGeAlD
Naloxone—ABCB1—spinal cord—germ cell cancer	0.000301	0.0014	CbGeAlD
Naloxone—CREB1—Adaptive Immune System—PVRL2—germ cell cancer	0.000301	0.00228	CbGpPWpGaD
Naloxone—Angiopathy—Methotrexate—germ cell cancer	0.000299	0.00494	CcSEcCtD
Naloxone—CREB1—Downstream signaling events of B Cell Receptor (BCR)—KIT—germ cell cancer	0.000299	0.00226	CbGpPWpGaD
Naloxone—Mediastinal disorder—Methotrexate—germ cell cancer	0.000297	0.0049	CcSEcCtD
Naloxone—Chills—Methotrexate—germ cell cancer	0.000296	0.00488	CcSEcCtD
Naloxone—Nausea—Ifosfamide—germ cell cancer	0.000294	0.00485	CcSEcCtD
Naloxone—CREB1—Regulation of nuclear SMAD2/3 signaling—MYC—germ cell cancer	0.000294	0.00222	CbGpPWpGaD
Naloxone—Diarrhoea—Cisplatin—germ cell cancer	0.000292	0.00482	CcSEcCtD
Naloxone—ABCB1—female gonad—germ cell cancer	0.000291	0.00136	CbGeAlD
Naloxone—Mental disorder—Methotrexate—germ cell cancer	0.000289	0.00477	CcSEcCtD
Naloxone—CREB1—B Cell Activation—FGFR3—germ cell cancer	0.000288	0.00218	CbGpPWpGaD
Naloxone—CREB1—Oncostatin M Signaling Pathway—TP53—germ cell cancer	0.000287	0.00218	CbGpPWpGaD
Naloxone—OPRD1—GPCR ligand binding—OXT—germ cell cancer	0.000287	0.00217	CbGpPWpGaD
Naloxone—CREB1—DAP12 interactions—KIT—germ cell cancer	0.000285	0.00216	CbGpPWpGaD
Naloxone—CREB1—Signaling by FGFR in disease—KIT—germ cell cancer	0.000285	0.00216	CbGpPWpGaD
Naloxone—CREB1—Fc epsilon receptor (FCERI) signaling—KIT—germ cell cancer	0.000285	0.00216	CbGpPWpGaD
Naloxone—OPRM1—Peptide ligand-binding receptors—AVP—germ cell cancer	0.000285	0.00216	CbGpPWpGaD
Naloxone—ALB—Platelet activation, signaling and aggregation—CD9—germ cell cancer	0.000285	0.00216	CbGpPWpGaD
Naloxone—CREB1—Signaling by NGF—KITLG—germ cell cancer	0.000285	0.00216	CbGpPWpGaD
Naloxone—CREB1—Signaling by EGFR—KIT—germ cell cancer	0.000283	0.00214	CbGpPWpGaD
Naloxone—Asthenia—Etoposide—germ cell cancer	0.000281	0.00463	CcSEcCtD
Naloxone—CREB1—Signaling by EGFR in Cancer—KIT—germ cell cancer	0.00028	0.00212	CbGpPWpGaD
Naloxone—OPRM1—Class A/1 (Rhodopsin-like receptors)—OXT—germ cell cancer	0.000279	0.00211	CbGpPWpGaD
Naloxone—CREB1—Signaling by PDGF—KIT—germ cell cancer	0.000279	0.00211	CbGpPWpGaD
Naloxone—CREB1—DNA Damage Response—TP53—germ cell cancer	0.000277	0.0021	CbGpPWpGaD
Naloxone—CREB1—G1 to S cell cycle control—TP53—germ cell cancer	0.000277	0.0021	CbGpPWpGaD
Naloxone—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—germ cell cancer	0.000276	0.00209	CbGpPWpGaD
Naloxone—CREB1—NGF signalling via TRKA from the plasma membrane—FGFR3—germ cell cancer	0.000275	0.00208	CbGpPWpGaD
Naloxone—CREB1—Oncostatin M Signaling Pathway—HRAS—germ cell cancer	0.000275	0.00208	CbGpPWpGaD
Naloxone—CREB1—TSH signaling pathway—HRAS—germ cell cancer	0.000272	0.00206	CbGpPWpGaD
Naloxone—Vomiting—Cisplatin—germ cell cancer	0.000272	0.00448	CcSEcCtD
Naloxone—TLR4—Immune System—KITLG—germ cell cancer	0.000271	0.00205	CbGpPWpGaD
Naloxone—ABCB1—endocrine gland—germ cell cancer	0.000271	0.00126	CbGeAlD
Naloxone—CREB1—AP-1 transcription factor network—TP53—germ cell cancer	0.000271	0.00205	CbGpPWpGaD
Naloxone—SLCO1A2—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	0.000268	0.00203	CbGpPWpGaD
Naloxone—CREB1—miRNA Regulation of DNA Damage Response—TP53—germ cell cancer	0.000268	0.00203	CbGpPWpGaD
Naloxone—Diarrhoea—Etoposide—germ cell cancer	0.000268	0.00442	CcSEcCtD
Naloxone—ABCB1—head—germ cell cancer	0.000267	0.00125	CbGeAlD
Naloxone—CREB1—NCAM signaling for neurite out-growth—HRAS—germ cell cancer	0.000265	0.00201	CbGpPWpGaD
Naloxone—CREB1—B Cell Activation—KIT—germ cell cancer	0.000264	0.002	CbGpPWpGaD
Naloxone—SLCO1A2—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	0.000264	0.002	CbGpPWpGaD
Naloxone—ESR1—LKB1 signaling events—TP53—germ cell cancer	0.000262	0.00198	CbGpPWpGaD
Naloxone—ESR1—Plasma membrane estrogen receptor signaling—HRAS—germ cell cancer	0.00026	0.00197	CbGpPWpGaD
Naloxone—ABCB1—testis—germ cell cancer	0.000258	0.00121	CbGeAlD
Naloxone—OPRD1—Class A/1 (Rhodopsin-like receptors)—AVP—germ cell cancer	0.000258	0.00196	CbGpPWpGaD
Naloxone—ALB—SLC-mediated transmembrane transport—SLC2A3—germ cell cancer	0.000258	0.00195	CbGpPWpGaD
Naloxone—CREB1—B Cell Receptor Signaling Pathway—MYC—germ cell cancer	0.000254	0.00192	CbGpPWpGaD
Naloxone—ALB—SLC-mediated transmembrane transport—SLC22A3—germ cell cancer	0.000254	0.00192	CbGpPWpGaD
Naloxone—Nausea—Cisplatin—germ cell cancer	0.000254	0.00418	CcSEcCtD
Naloxone—CREB1—NGF signalling via TRKA from the plasma membrane—KIT—germ cell cancer	0.000253	0.00191	CbGpPWpGaD
Naloxone—OPRK1—GPCR ligand binding—OXT—germ cell cancer	0.000252	0.0019	CbGpPWpGaD
Naloxone—Convulsion—Methotrexate—germ cell cancer	0.000249	0.0041	CcSEcCtD
Naloxone—Vomiting—Etoposide—germ cell cancer	0.000249	0.0041	CcSEcCtD
Naloxone—CREB1—Leptin signaling pathway—HRAS—germ cell cancer	0.000245	0.00186	CbGpPWpGaD
Naloxone—SLCO1A2—SLC-mediated transmembrane transport—AVP—germ cell cancer	0.000243	0.00184	CbGpPWpGaD
Naloxone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—germ cell cancer	0.000243	0.004	CcSEcCtD
Naloxone—CREB1—Glucocorticoid receptor regulatory network—TP53—germ cell cancer	0.000239	0.00181	CbGpPWpGaD
Naloxone—ABCB1—cerebellum—germ cell cancer	0.000239	0.00111	CbGeAlD
Naloxone—ESR1—Aryl Hydrocarbon Receptor—HRAS—germ cell cancer	0.000237	0.0018	CbGpPWpGaD
Naloxone—Nausea—Etoposide—germ cell cancer	0.000232	0.00383	CcSEcCtD
Naloxone—ESR1—Validated nuclear estrogen receptor alpha network—MYC—germ cell cancer	0.000232	0.00176	CbGpPWpGaD
Naloxone—CREB1—Signaling by NOTCH—MYC—germ cell cancer	0.000231	0.00175	CbGpPWpGaD
Naloxone—ESR1—Signaling by ERBB4—FGFR3—germ cell cancer	0.00023	0.00174	CbGpPWpGaD
Naloxone—Nervous system disorder—Methotrexate—germ cell cancer	0.00023	0.00379	CcSEcCtD
Naloxone—Skin disorder—Methotrexate—germ cell cancer	0.000228	0.00375	CcSEcCtD
Naloxone—Hyperhidrosis—Methotrexate—germ cell cancer	0.000227	0.00374	CcSEcCtD
Naloxone—OPRK1—Class A/1 (Rhodopsin-like receptors)—AVP—germ cell cancer	0.000226	0.00171	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	0.000226	0.00171	CbGpPWpGaD
Naloxone—ESR1—Regulation of Telomerase—MYC—germ cell cancer	0.000221	0.00167	CbGpPWpGaD
Naloxone—ESR1—Gene Expression—NR0B1—germ cell cancer	0.000221	0.00167	CbGpPWpGaD
Naloxone—ESR1—AP-1 transcription factor network—MYC—germ cell cancer	0.000216	0.00164	CbGpPWpGaD
Naloxone—OPRM1—GPCR ligand binding—OXT—germ cell cancer	0.000213	0.00161	CbGpPWpGaD
Naloxone—CREB1—TCR Signaling Pathway—HRAS—germ cell cancer	0.000212	0.0016	CbGpPWpGaD
Naloxone—CREB1—Signaling by NGF—FGFR3—germ cell cancer	0.000212	0.0016	CbGpPWpGaD
Naloxone—ESR1—Signaling by ERBB4—KIT—germ cell cancer	0.000211	0.0016	CbGpPWpGaD
Naloxone—Paraesthesia—Methotrexate—germ cell cancer	0.00021	0.00347	CcSEcCtD
Naloxone—Dyspnoea—Methotrexate—germ cell cancer	0.000209	0.00345	CcSEcCtD
Naloxone—Gastrointestinal disorder—Methotrexate—germ cell cancer	0.000202	0.00334	CcSEcCtD
Naloxone—TLR4—Immune System—FGFR3—germ cell cancer	0.000202	0.00153	CbGpPWpGaD
Naloxone—Pain—Methotrexate—germ cell cancer	0.0002	0.00331	CcSEcCtD
Naloxone—ALB—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	0.0002	0.00152	CbGpPWpGaD
Naloxone—CREB1—B Cell Receptor Signaling Pathway—HRAS—germ cell cancer	0.0002	0.00151	CbGpPWpGaD
Naloxone—CREB1—Innate Immune System—FGF4—germ cell cancer	0.000198	0.0015	CbGpPWpGaD
Naloxone—OPRD1—GPCR ligand binding—AVP—germ cell cancer	0.000197	0.00149	CbGpPWpGaD
Naloxone—CREB1—Signaling by NGF—KIT—germ cell cancer	0.000194	0.00147	CbGpPWpGaD
Naloxone—ABCB1—brain—germ cell cancer	0.000194	0.000905	CbGeAlD
Naloxone—ESR1—Regulation of nuclear SMAD2/3 signaling—MYC—germ cell cancer	0.000192	0.00146	CbGpPWpGaD
Naloxone—ESR1—Gene Expression—DNMT3L—germ cell cancer	0.000191	0.00145	CbGpPWpGaD
Naloxone—OPRM1—Class A/1 (Rhodopsin-like receptors)—AVP—germ cell cancer	0.000191	0.00145	CbGpPWpGaD
Naloxone—CREB1—Signaling by NOTCH—TP53—germ cell cancer	0.00019	0.00144	CbGpPWpGaD
Naloxone—CREB1—Adaptive Immune System—FGF4—germ cell cancer	0.00019	0.00144	CbGpPWpGaD
Naloxone—CREB1—ErbB1 downstream signaling—HRAS—germ cell cancer	0.000187	0.00142	CbGpPWpGaD
Naloxone—ABCB1—lymph node—germ cell cancer	0.000187	0.000874	CbGeAlD
Naloxone—Body temperature increased—Methotrexate—germ cell cancer	0.000185	0.00306	CcSEcCtD
Naloxone—Abdominal pain—Methotrexate—germ cell cancer	0.000185	0.00306	CcSEcCtD
Naloxone—CREB1—Disease—SLC2A3—germ cell cancer	0.000185	0.0014	CbGpPWpGaD
Naloxone—TLR4—Immune System—KIT—germ cell cancer	0.000185	0.0014	CbGpPWpGaD
Naloxone—CREB1—Immune System—PVRL2—germ cell cancer	0.000182	0.00138	CbGpPWpGaD
Naloxone—CREB1—Integrated Breast Cancer Pathway—MYC—germ cell cancer	0.000178	0.00135	CbGpPWpGaD
Naloxone—ESR1—Gene Expression—RARS—germ cell cancer	0.000178	0.00135	CbGpPWpGaD
Naloxone—ESR1—AP-1 transcription factor network—TP53—germ cell cancer	0.000177	0.00134	CbGpPWpGaD
Naloxone—ABCB1—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	0.000175	0.00133	CbGpPWpGaD
Naloxone—OPRK1—GPCR ligand binding—AVP—germ cell cancer	0.000172	0.00131	CbGpPWpGaD
Naloxone—Asthenia—Methotrexate—germ cell cancer	0.000168	0.00277	CcSEcCtD
Naloxone—CREB1—Innate Immune System—KITLG—germ cell cancer	0.000163	0.00123	CbGpPWpGaD
Naloxone—OPRD1—GPCR downstream signaling—OXT—germ cell cancer	0.000162	0.00123	CbGpPWpGaD
Naloxone—ESR1—Leptin signaling pathway—HRAS—germ cell cancer	0.000161	0.00122	CbGpPWpGaD
Naloxone—Diarrhoea—Methotrexate—germ cell cancer	0.00016	0.00264	CcSEcCtD
Naloxone—OPRM1—TCR Signaling Pathway—HRAS—germ cell cancer	0.000157	0.00118	CbGpPWpGaD
Naloxone—CREB1—Adaptive Immune System—KITLG—germ cell cancer	0.000156	0.00118	CbGpPWpGaD
Naloxone—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—germ cell cancer	0.000152	0.00115	CbGpPWpGaD
Naloxone—Vomiting—Methotrexate—germ cell cancer	0.000149	0.00246	CcSEcCtD
Naloxone—CREB1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—germ cell cancer	0.000149	0.00113	CbGpPWpGaD
Naloxone—CREB1—Signaling by SCF-KIT—HRAS—germ cell cancer	0.000148	0.00112	CbGpPWpGaD
Naloxone—CREB1—Integrated Pancreatic Cancer Pathway—MYC—germ cell cancer	0.000148	0.00112	CbGpPWpGaD
Naloxone—CREB1—Signaling by GPCR—OXT—germ cell cancer	0.000148	0.00112	CbGpPWpGaD
Naloxone—OPRD1—Signaling by GPCR—OXT—germ cell cancer	0.000147	0.00111	CbGpPWpGaD
Naloxone—ALB—Hemostasis—CD9—germ cell cancer	0.000147	0.00111	CbGpPWpGaD
Naloxone—CREB1—Integrated Breast Cancer Pathway—TP53—germ cell cancer	0.000146	0.00111	CbGpPWpGaD
Naloxone—OPRM1—GPCR ligand binding—AVP—germ cell cancer	0.000146	0.0011	CbGpPWpGaD
Naloxone—CREB1—BDNF signaling pathway—HRAS—germ cell cancer	0.000145	0.0011	CbGpPWpGaD
Naloxone—OPRK1—GPCR downstream signaling—OXT—germ cell cancer	0.000142	0.00108	CbGpPWpGaD
Naloxone—CREB1—Downstream signaling of activated FGFR—HRAS—germ cell cancer	0.000142	0.00107	CbGpPWpGaD
Naloxone—CREB1—Signaling by ERBB4—HRAS—germ cell cancer	0.000139	0.00105	CbGpPWpGaD
Naloxone—Nausea—Methotrexate—germ cell cancer	0.000139	0.0023	CcSEcCtD
Naloxone—TLR4—Innate Immune System—HRAS—germ cell cancer	0.000137	0.00104	CbGpPWpGaD
Naloxone—CREB1—Downstream signal transduction—HRAS—germ cell cancer	0.000133	0.00101	CbGpPWpGaD
Naloxone—CREB1—Signaling by FGFR—HRAS—germ cell cancer	0.000132	0.001	CbGpPWpGaD
Naloxone—CREB1—EGF/EGFR Signaling Pathway—HRAS—germ cell cancer	0.000132	0.001	CbGpPWpGaD
Naloxone—CREB1—Signaling by ERBB2—HRAS—germ cell cancer	0.000132	0.000997	CbGpPWpGaD
Naloxone—CREB1—DAP12 signaling—HRAS—germ cell cancer	0.000131	0.000992	CbGpPWpGaD
Naloxone—ALB—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	0.000131	0.000992	CbGpPWpGaD
Naloxone—CREB1—Downstream signaling events of B Cell Receptor (BCR)—HRAS—germ cell cancer	0.000129	0.000978	CbGpPWpGaD
Naloxone—OPRK1—Signaling by GPCR—OXT—germ cell cancer	0.000129	0.000978	CbGpPWpGaD
Naloxone—ALB—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	0.000129	0.000977	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism—SLC2A3—germ cell cancer	0.000126	0.000951	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism—SLC22A3—germ cell cancer	0.000124	0.000936	CbGpPWpGaD
Naloxone—SLCO1A2—Transmembrane transport of small molecules—AVP—germ cell cancer	0.000124	0.000936	CbGpPWpGaD
Naloxone—CREB1—DAP12 interactions—HRAS—germ cell cancer	0.000123	0.000934	CbGpPWpGaD
Naloxone—CREB1—Fc epsilon receptor (FCERI) signaling—HRAS—germ cell cancer	0.000123	0.000934	CbGpPWpGaD
Naloxone—CREB1—Signaling by FGFR in disease—HRAS—germ cell cancer	0.000123	0.000934	CbGpPWpGaD
Naloxone—CREB1—Signaling by EGFR—HRAS—germ cell cancer	0.000122	0.000925	CbGpPWpGaD
Naloxone—CREB1—Integrated Pancreatic Cancer Pathway—TP53—germ cell cancer	0.000121	0.000919	CbGpPWpGaD
Naloxone—CREB1—Signaling by EGFR in Cancer—HRAS—germ cell cancer	0.000121	0.000917	CbGpPWpGaD
Naloxone—CREB1—Innate Immune System—FGFR3—germ cell cancer	0.000121	0.000914	CbGpPWpGaD
Naloxone—CREB1—Signaling by PDGF—HRAS—germ cell cancer	0.000121	0.000913	CbGpPWpGaD
Naloxone—OPRM1—GPCR downstream signaling—OXT—germ cell cancer	0.00012	0.00091	CbGpPWpGaD
Naloxone—ALB—SLC-mediated transmembrane transport—AVP—germ cell cancer	0.000119	0.0009	CbGpPWpGaD
Naloxone—ESR1—Integrated Breast Cancer Pathway—MYC—germ cell cancer	0.000117	0.000884	CbGpPWpGaD
Naloxone—CREB1—Circadian rythm related genes—TP53—germ cell cancer	0.000117	0.000882	CbGpPWpGaD
Naloxone—CREB1—Adaptive Immune System—FGFR3—germ cell cancer	0.000116	0.000878	CbGpPWpGaD
Naloxone—CREB1—Immune System—FGF4—germ cell cancer	0.000115	0.000872	CbGpPWpGaD
Naloxone—ABCB1—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	0.000115	0.000869	CbGpPWpGaD
Naloxone—CREB1—B Cell Activation—HRAS—germ cell cancer	0.000114	0.000864	CbGpPWpGaD
Naloxone—ABCB1—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	0.000113	0.000856	CbGpPWpGaD
Naloxone—ALB—Folate Metabolism—TP53—germ cell cancer	0.000112	0.00085	CbGpPWpGaD
Naloxone—CREB1—Transmission across Chemical Synapses—HRAS—germ cell cancer	0.000112	0.000847	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	0.000111	0.000842	CbGpPWpGaD
Naloxone—OPRD1—GPCR downstream signaling—AVP—germ cell cancer	0.000111	0.000841	CbGpPWpGaD
Naloxone—CREB1—Innate Immune System—KIT—germ cell cancer	0.000111	0.000839	CbGpPWpGaD
Naloxone—ALB—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	0.000111	0.000837	CbGpPWpGaD
Naloxone—CREB1—NGF signalling via TRKA from the plasma membrane—HRAS—germ cell cancer	0.000109	0.000827	CbGpPWpGaD
Naloxone—OPRM1—Signaling by GPCR—OXT—germ cell cancer	0.000109	0.000826	CbGpPWpGaD
Naloxone—CREB1—Adaptive Immune System—KIT—germ cell cancer	0.000106	0.000806	CbGpPWpGaD
Naloxone—CREB1—Disease—FGF4—germ cell cancer	0.000106	0.000805	CbGpPWpGaD
Naloxone—CREB1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—germ cell cancer	0.000106	0.000799	CbGpPWpGaD
Naloxone—CREB1—Signaling by GPCR—AVP—germ cell cancer	0.000101	0.000767	CbGpPWpGaD
Naloxone—OPRD1—Signaling by GPCR—AVP—germ cell cancer	0.000101	0.000764	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism—CRABP1—germ cell cancer	0.000101	0.000763	CbGpPWpGaD
Naloxone—OPRK1—GPCR downstream signaling—AVP—germ cell cancer	9.75e-05	0.000738	CbGpPWpGaD
Naloxone—ESR1—Integrated Pancreatic Cancer Pathway—MYC—germ cell cancer	9.68e-05	0.000733	CbGpPWpGaD
Naloxone—ESR1—Integrated Breast Cancer Pathway—TP53—germ cell cancer	9.59e-05	0.000726	CbGpPWpGaD
Naloxone—CREB1—Disease—H2AFZ—germ cell cancer	9.5e-05	0.000719	CbGpPWpGaD
Naloxone—CREB1—Immune System—KITLG—germ cell cancer	9.47e-05	0.000717	CbGpPWpGaD
Naloxone—ESR1—Signaling by ERBB4—HRAS—germ cell cancer	9.13e-05	0.000691	CbGpPWpGaD
Naloxone—OPRK1—Signaling by GPCR—AVP—germ cell cancer	8.85e-05	0.00067	CbGpPWpGaD
Naloxone—CREB1—Disease—KITLG—germ cell cancer	8.74e-05	0.000662	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—OXT—germ cell cancer	8.73e-05	0.000661	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—OXT—germ cell cancer	8.7e-05	0.000659	CbGpPWpGaD
Naloxone—CREB1—Neuronal System—HRAS—germ cell cancer	8.57e-05	0.000649	CbGpPWpGaD
Naloxone—CREB1—Signaling by NGF—HRAS—germ cell cancer	8.4e-05	0.000636	CbGpPWpGaD
Naloxone—OPRM1—GPCR downstream signaling—AVP—germ cell cancer	8.24e-05	0.000624	CbGpPWpGaD
Naloxone—TLR4—Immune System—HRAS—germ cell cancer	8e-05	0.000605	CbGpPWpGaD
Naloxone—ESR1—Integrated Pancreatic Cancer Pathway—TP53—germ cell cancer	7.95e-05	0.000602	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—OXT—germ cell cancer	7.63e-05	0.000577	CbGpPWpGaD
Naloxone—CREB1—Axon guidance—HRAS—germ cell cancer	7.6e-05	0.000576	CbGpPWpGaD
Naloxone—OPRM1—Signaling by GPCR—AVP—germ cell cancer	7.48e-05	0.000566	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—FGF4—germ cell cancer	7.45e-05	0.000564	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—FGF4—germ cell cancer	7.43e-05	0.000562	CbGpPWpGaD
Naloxone—CREB1—Immune System—FGFR3—germ cell cancer	7.04e-05	0.000533	CbGpPWpGaD
Naloxone—ESR1—Gene Expression—H2AFZ—germ cell cancer	6.7e-05	0.000507	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—H2AFZ—germ cell cancer	6.65e-05	0.000504	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—H2AFZ—germ cell cancer	6.63e-05	0.000502	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—FGF4—germ cell cancer	6.51e-05	0.000493	CbGpPWpGaD
Naloxone—CREB1—Disease—FGFR3—germ cell cancer	6.5e-05	0.000492	CbGpPWpGaD
Naloxone—CREB1—Immune System—KIT—germ cell cancer	6.46e-05	0.000489	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—OXT—germ cell cancer	6.45e-05	0.000488	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—SLC2A3—germ cell cancer	6.17e-05	0.000467	CbGpPWpGaD
Naloxone—ALB—Metabolism—SLC2A3—germ cell cancer	6.14e-05	0.000464	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—KITLG—germ cell cancer	6.12e-05	0.000463	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—KITLG—germ cell cancer	6.1e-05	0.000462	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—SLC22A3—germ cell cancer	6.08e-05	0.00046	CbGpPWpGaD
Naloxone—ALB—Metabolism—SLC22A3—germ cell cancer	6.04e-05	0.000457	CbGpPWpGaD
Naloxone—ALB—Transmembrane transport of small molecules—AVP—germ cell cancer	6.04e-05	0.000457	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—AVP—germ cell cancer	5.98e-05	0.000453	CbGpPWpGaD
Naloxone—CREB1—Disease—KIT—germ cell cancer	5.96e-05	0.000451	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—AVP—germ cell cancer	5.96e-05	0.000451	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—H2AFZ—germ cell cancer	5.81e-05	0.00044	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—OXT—germ cell cancer	5.72e-05	0.000433	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—FGF4—germ cell cancer	5.5e-05	0.000417	CbGpPWpGaD
Naloxone—CREB1—Developmental Biology—HRAS—germ cell cancer	5.43e-05	0.000411	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—SLC2A3—germ cell cancer	5.38e-05	0.000407	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—KITLG—germ cell cancer	5.35e-05	0.000405	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—SLC22A3—germ cell cancer	5.3e-05	0.000401	CbGpPWpGaD
Naloxone—ABCB1—Transmembrane transport of small molecules—AVP—germ cell cancer	5.29e-05	0.000401	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—AVP—germ cell cancer	5.23e-05	0.000396	CbGpPWpGaD
Naloxone—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—germ cell cancer	5.12e-05	0.000388	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—CRABP1—germ cell cancer	4.95e-05	0.000375	CbGpPWpGaD
Naloxone—ALB—Metabolism—CRABP1—germ cell cancer	4.93e-05	0.000373	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—H2AFZ—germ cell cancer	4.91e-05	0.000372	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—FGF4—germ cell cancer	4.88e-05	0.000369	CbGpPWpGaD
Naloxone—ESR1—Generic Transcription Pathway—MYC—germ cell cancer	4.81e-05	0.000364	CbGpPWpGaD
Naloxone—CREB1—Innate Immune System—HRAS—germ cell cancer	4.79e-05	0.000363	CbGpPWpGaD
Naloxone—CREB1—Adaptive Immune System—HRAS—germ cell cancer	4.6e-05	0.000348	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—FGFR3—germ cell cancer	4.55e-05	0.000344	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—FGFR3—germ cell cancer	4.53e-05	0.000343	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—KITLG—germ cell cancer	4.52e-05	0.000342	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—AVP—germ cell cancer	4.42e-05	0.000334	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—H2AFZ—germ cell cancer	4.36e-05	0.00033	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—CRABP1—germ cell cancer	4.32e-05	0.000327	CbGpPWpGaD
Naloxone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—germ cell cancer	4.21e-05	0.000318	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—KIT—germ cell cancer	4.18e-05	0.000316	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—KIT—germ cell cancer	4.16e-05	0.000315	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—KITLG—germ cell cancer	4.01e-05	0.000303	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—FGFR3—germ cell cancer	3.98e-05	0.000301	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—AVP—germ cell cancer	3.92e-05	0.000297	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—KIT—germ cell cancer	3.65e-05	0.000276	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—FGFR3—germ cell cancer	3.36e-05	0.000254	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—SLC2A3—germ cell cancer	3.31e-05	0.000251	CbGpPWpGaD
Naloxone—CREB1—Disease—MYC—germ cell cancer	3.28e-05	0.000248	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—SLC22A3—germ cell cancer	3.26e-05	0.000247	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—KIT—germ cell cancer	3.09e-05	0.000234	CbGpPWpGaD
Naloxone—CREB1—Signaling by GPCR—HRAS—germ cell cancer	3.06e-05	0.000231	CbGpPWpGaD
Naloxone—OPRD1—Signaling by GPCR—HRAS—germ cell cancer	3.05e-05	0.000231	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—FGFR3—germ cell cancer	2.98e-05	0.000226	CbGpPWpGaD
Naloxone—CREB1—Immune System—HRAS—germ cell cancer	2.79e-05	0.000211	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—KIT—germ cell cancer	2.74e-05	0.000207	CbGpPWpGaD
Naloxone—OPRK1—Signaling by GPCR—HRAS—germ cell cancer	2.67e-05	0.000202	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—CRABP1—germ cell cancer	2.66e-05	0.000201	CbGpPWpGaD
Naloxone—CREB1—Disease—HRAS—germ cell cancer	2.58e-05	0.000195	CbGpPWpGaD
Naloxone—ESR1—Gene Expression—MYC—germ cell cancer	2.31e-05	0.000175	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—MYC—germ cell cancer	2.3e-05	0.000174	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—MYC—germ cell cancer	2.29e-05	0.000173	CbGpPWpGaD
Naloxone—OPRM1—Signaling by GPCR—HRAS—germ cell cancer	2.26e-05	0.000171	CbGpPWpGaD
Naloxone—ALB—Hemostasis—TP53—germ cell cancer	2.2e-05	0.000167	CbGpPWpGaD
Naloxone—ALB—Hemostasis—HRAS—germ cell cancer	2.11e-05	0.000159	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—MYC—germ cell cancer	2.01e-05	0.000152	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—TP53—germ cell cancer	1.89e-05	0.000143	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—TP53—germ cell cancer	1.88e-05	0.000142	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—HRAS—germ cell cancer	1.8e-05	0.000137	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—HRAS—germ cell cancer	1.8e-05	0.000136	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—MYC—germ cell cancer	1.7e-05	0.000128	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—TP53—germ cell cancer	1.65e-05	0.000125	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—HRAS—germ cell cancer	1.58e-05	0.000119	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—MYC—germ cell cancer	1.51e-05	0.000114	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—TP53—germ cell cancer	1.39e-05	0.000106	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—HRAS—germ cell cancer	1.33e-05	0.000101	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—TP53—germ cell cancer	1.24e-05	9.36e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—HRAS—germ cell cancer	1.18e-05	8.95e-05	CbGpPWpGaD
